The project on LCA will last five years, and has the ambitious goals to develop gene therapy for other types of LCA, after the RPE65 trial success. As far as I know, the focus will be on the CEP290 gene, LCA10, which is the main cause of Leber's. This part of the project will begin with research on the RD16 mouse and the Abyssinian cat (naturally occurring animal models of CEP290 LCA), and finally, if all goes well, on humans!!
Here are a couple of links to learn more
http://www.mcgill.ca/newsroom/news/item/?item_id=103088
http://www.gtamotorcycle.com/vbforum/showthread.php?p=770014#post770014
0 comments:
Post a Comment